phase 2 saq 3 Flashcards
first line treatment for unstable angina
GTN spray (1 mark) and either B-blocker or Calcium Channel Blocker
extra-articular manifestations of ankylosing spondylitis
5 A’s: anterior uveitis (2), autoimmune bowel disease (2), apical lung fibrosis (2), aortic regurgitation (2), amyloidosis
ankylosing spondylitis management
NSAIDS (1), Steroids during flares (1), Anti-TNF
describe moderate asthma
PEFR more than 50-75% best or predicted and normal speech, with no features of acute severe or
life-threatening asthma.
descrbe acute severe asthma
PEFR 33-50% best or predicted (less than 50% best or
predicted in children) or respiratory rate of at least 25/min in people over the age of 12 years, 30/min in children between the ages of 5-12 years, and 40/min in children between 2-5 years old, or pulse rate of at least 110/min in people over the age of 12 years, 125/min in children between the ages of 5-12 years, and 140/min in children between 2-5 years old, or inability to complete sentences in one breath, or accessory muscle use, or inability to feed (infants), with oxygen saturation of at least 92%
describe life threatning asthma
PEFR less than 33% best or predicted, or oxygen saturation of less than 92%, or altered consciousness, IorI poor respiratory effort, or silent chest, or confusion.
indications of good asthma control
No night-time symptoms
● Inhaler used no more than three times per week
● No breathing difficulties, cough or wheeze on most days
● Able to exercise without symptoms
● Normal lung function test
adrenaline mechanism of action
Stimulation / agonist (1) of beta (1) adrenergic (1) receptors
physiological responses to mediators of anaphylaxis
Vasodilation (1), Increased vascular permeability (1), tachycardia (1), hypotension (1), maximise blood glucose levels in brain
non malignant causes of lymphadenopathy
infection, sarcoidosis, phenytoin, EBV associated lymphoproliferative disease, SLE
symotoms of CLL
anorexia, weight loss, fatigue, bleedings, infections, abdominal pain
additional test to confirm CLL diagnosis
Immunophenotyping
3 treatments for CLL
- chemotherapy
- radiotherpay
- stem cell transplant
non-pharmacological management options for OA
Patient education (1), activity / exercise (1), weight loss (1), improved diet (1) - anti-inflammatory foods physiotherapy (1), occupational therapy
topical management for OA
NSAIDs (1), capsaicin
oral managemnt of OA
paracetamol (1), NSAIDs (1), opioids (1), bisphosphonates
What treatment would you prescribe Trevor to prevent stroke AFTER tia
aspirin
treatment for ischaemic total anterior circulation stroke
thrombolysis / Alteplase within 4.5 hours
chest x ray for TB
Bilateral hilar lymphadenopathy (1), ghon focus